nodes	percent_of_prediction	percent_of_DWPC	metapath
Methacholine—L-Carnitine—MPO—hematologic cancer	0.00341	1	CrCbGaD
Methacholine—Chest pain—Vinorelbine—hematologic cancer	0.00151	0.00161	CcSEcCtD
Methacholine—Hypotension—Lenalidomide—hematologic cancer	0.00151	0.0016	CcSEcCtD
Methacholine—Pruritus—Busulfan—hematologic cancer	0.0015	0.00159	CcSEcCtD
Methacholine—Vomiting—Idarubicin—hematologic cancer	0.00149	0.00159	CcSEcCtD
Methacholine—Cough—Thiotepa—hematologic cancer	0.00148	0.00157	CcSEcCtD
Methacholine—Nausea—Mercaptopurine—hematologic cancer	0.00147	0.00157	CcSEcCtD
Methacholine—Headache—Idarubicin—hematologic cancer	0.00147	0.00157	CcSEcCtD
Methacholine—Syncope—Thalidomide—hematologic cancer	0.00147	0.00156	CcSEcCtD
Methacholine—Shock—Bortezomib—hematologic cancer	0.00146	0.00155	CcSEcCtD
Methacholine—Pruritus—Procarbazine—hematologic cancer	0.00145	0.00155	CcSEcCtD
Methacholine—Nausea—Daunorubicin—hematologic cancer	0.00145	0.00155	CcSEcCtD
Methacholine—Nausea—Clofarabine—hematologic cancer	0.00145	0.00155	CcSEcCtD
Methacholine—Vomiting—Teniposide—hematologic cancer	0.00145	0.00155	CcSEcCtD
Methacholine—Nausea—Pentostatin—hematologic cancer	0.00145	0.00154	CcSEcCtD
Methacholine—Nausea—Anagrelide—hematologic cancer	0.00145	0.00154	CcSEcCtD
Methacholine—Loss of consciousness—Thalidomide—hematologic cancer	0.00144	0.00153	CcSEcCtD
Methacholine—Headache—Teniposide—hematologic cancer	0.00143	0.00152	CcSEcCtD
Methacholine—Cough—Thalidomide—hematologic cancer	0.00143	0.00152	CcSEcCtD
Methacholine—Pruritus—Bexarotene—hematologic cancer	0.00143	0.00152	CcSEcCtD
Methacholine—Pruritus—Dasatinib—hematologic cancer	0.00143	0.00152	CcSEcCtD
Methacholine—Pruritus—Fludarabine—hematologic cancer	0.00142	0.00151	CcSEcCtD
Methacholine—Bradycardia—Prednisolone—hematologic cancer	0.0014	0.00149	CcSEcCtD
Methacholine—Dizziness—Busulfan—hematologic cancer	0.0014	0.00149	CcSEcCtD
Methacholine—Syncope—Alitretinoin—hematologic cancer	0.0014	0.00149	CcSEcCtD
Methacholine—Chest pain—Thalidomide—hematologic cancer	0.0014	0.00148	CcSEcCtD
Methacholine—Nausea—Idarubicin—hematologic cancer	0.0014	0.00148	CcSEcCtD
Methacholine—Hypotension—Bortezomib—hematologic cancer	0.00139	0.00147	CcSEcCtD
Methacholine—Cardiac arrest—Prednisone—hematologic cancer	0.00138	0.00147	CcSEcCtD
Methacholine—Hypotension—Bleomycin—hematologic cancer	0.00138	0.00146	CcSEcCtD
Methacholine—Loss of consciousness—Alitretinoin—hematologic cancer	0.00137	0.00146	CcSEcCtD
Methacholine—Cough—Alitretinoin—hematologic cancer	0.00136	0.00145	CcSEcCtD
Methacholine—Dizziness—Procarbazine—hematologic cancer	0.00136	0.00145	CcSEcCtD
Methacholine—Nausea—Teniposide—hematologic cancer	0.00136	0.00144	CcSEcCtD
Methacholine—Hypotension—Vinorelbine—hematologic cancer	0.00135	0.00144	CcSEcCtD
Methacholine—Vomiting—Busulfan—hematologic cancer	0.00135	0.00143	CcSEcCtD
Methacholine—Pruritus—Chlorambucil—hematologic cancer	0.00135	0.00143	CcSEcCtD
Methacholine—Cough—Ifosfamide—hematologic cancer	0.00135	0.00143	CcSEcCtD
Methacholine—Chest pain—Carmustine—hematologic cancer	0.00134	0.00143	CcSEcCtD
Methacholine—Dizziness—Dasatinib—hematologic cancer	0.00133	0.00142	CcSEcCtD
Methacholine—Dizziness—Bexarotene—hematologic cancer	0.00133	0.00142	CcSEcCtD
Methacholine—Chest pain—Alitretinoin—hematologic cancer	0.00133	0.00141	CcSEcCtD
Methacholine—Headache—Busulfan—hematologic cancer	0.00133	0.00141	CcSEcCtD
Methacholine—Shock—Thalidomide—hematologic cancer	0.00132	0.0014	CcSEcCtD
Methacholine—Pruritus—Nilotinib—hematologic cancer	0.00132	0.0014	CcSEcCtD
Methacholine—Syncope—Irinotecan—hematologic cancer	0.00131	0.0014	CcSEcCtD
Methacholine—Chest pain—Ifosfamide—hematologic cancer	0.00131	0.0014	CcSEcCtD
Methacholine—Pruritus—Imatinib—hematologic cancer	0.00131	0.00139	CcSEcCtD
Methacholine—Vomiting—Procarbazine—hematologic cancer	0.00131	0.00139	CcSEcCtD
Methacholine—Bradycardia—Triamcinolone—hematologic cancer	0.00129	0.00137	CcSEcCtD
Methacholine—Headache—Procarbazine—hematologic cancer	0.00129	0.00137	CcSEcCtD
Methacholine—Loss of consciousness—Irinotecan—hematologic cancer	0.00129	0.00137	CcSEcCtD
Methacholine—Pruritus—Cladribine—hematologic cancer	0.00129	0.00137	CcSEcCtD
Methacholine—Vomiting—Dasatinib—hematologic cancer	0.00128	0.00136	CcSEcCtD
Methacholine—Vomiting—Bexarotene—hematologic cancer	0.00128	0.00136	CcSEcCtD
Methacholine—Cough—Mitoxantrone—hematologic cancer	0.00128	0.00136	CcSEcCtD
Methacholine—Cough—Irinotecan—hematologic cancer	0.00128	0.00136	CcSEcCtD
Methacholine—Vomiting—Fludarabine—hematologic cancer	0.00128	0.00136	CcSEcCtD
Methacholine—Headache—Dasatinib—hematologic cancer	0.00126	0.00134	CcSEcCtD
Methacholine—Headache—Bexarotene—hematologic cancer	0.00126	0.00134	CcSEcCtD
Methacholine—Headache—Fludarabine—hematologic cancer	0.00126	0.00134	CcSEcCtD
Methacholine—Nausea—Busulfan—hematologic cancer	0.00126	0.00134	CcSEcCtD
Methacholine—Shock—Alitretinoin—hematologic cancer	0.00125	0.00133	CcSEcCtD
Methacholine—Hypotension—Thalidomide—hematologic cancer	0.00125	0.00133	CcSEcCtD
Methacholine—Chest pain—Mitoxantrone—hematologic cancer	0.00125	0.00133	CcSEcCtD
Methacholine—Cough—Gemcitabine—hematologic cancer	0.00124	0.00132	CcSEcCtD
Methacholine—Dizziness—Nilotinib—hematologic cancer	0.00123	0.00131	CcSEcCtD
Methacholine—Dizziness—Imatinib—hematologic cancer	0.00122	0.0013	CcSEcCtD
Methacholine—Nausea—Procarbazine—hematologic cancer	0.00122	0.0013	CcSEcCtD
Methacholine—Chest pain—Gemcitabine—hematologic cancer	0.00121	0.00129	CcSEcCtD
Methacholine—Vomiting—Chlorambucil—hematologic cancer	0.00121	0.00129	CcSEcCtD
Methacholine—Dizziness—Cladribine—hematologic cancer	0.0012	0.00128	CcSEcCtD
Methacholine—Hypotension—Carmustine—hematologic cancer	0.0012	0.00128	CcSEcCtD
Methacholine—Nausea—Dasatinib—hematologic cancer	0.0012	0.00127	CcSEcCtD
Methacholine—Nausea—Bexarotene—hematologic cancer	0.0012	0.00127	CcSEcCtD
Methacholine—Nausea—Fludarabine—hematologic cancer	0.00119	0.00127	CcSEcCtD
Methacholine—Hypotension—Alitretinoin—hematologic cancer	0.00119	0.00127	CcSEcCtD
Methacholine—Vomiting—Nilotinib—hematologic cancer	0.00118	0.00126	CcSEcCtD
Methacholine—Vomiting—Imatinib—hematologic cancer	0.00118	0.00125	CcSEcCtD
Methacholine—Hypotension—Ifosfamide—hematologic cancer	0.00118	0.00125	CcSEcCtD
Methacholine—Shock—Irinotecan—hematologic cancer	0.00118	0.00125	CcSEcCtD
Methacholine—Shock—Mitoxantrone—hematologic cancer	0.00118	0.00125	CcSEcCtD
Methacholine—Pruritus—Melphalan—hematologic cancer	0.00117	0.00125	CcSEcCtD
Methacholine—Bradycardia—Betamethasone—hematologic cancer	0.00117	0.00125	CcSEcCtD
Methacholine—Bradycardia—Dexamethasone—hematologic cancer	0.00117	0.00125	CcSEcCtD
Methacholine—Headache—Nilotinib—hematologic cancer	0.00117	0.00124	CcSEcCtD
Methacholine—Headache—Imatinib—hematologic cancer	0.00116	0.00123	CcSEcCtD
Methacholine—Vomiting—Cladribine—hematologic cancer	0.00116	0.00123	CcSEcCtD
Methacholine—Dizziness—Vinblastine—hematologic cancer	0.00115	0.00123	CcSEcCtD
Methacholine—Hypotension—Vincristine—hematologic cancer	0.00115	0.00122	CcSEcCtD
Methacholine—Pruritus—Lenalidomide—hematologic cancer	0.00114	0.00121	CcSEcCtD
Methacholine—Headache—Cladribine—hematologic cancer	0.00114	0.00121	CcSEcCtD
Methacholine—Nausea—Chlorambucil—hematologic cancer	0.00113	0.0012	CcSEcCtD
Methacholine—Hypotension—Mitoxantrone—hematologic cancer	0.00112	0.00119	CcSEcCtD
Methacholine—Hypotension—Irinotecan—hematologic cancer	0.00112	0.00119	CcSEcCtD
Methacholine—Vomiting—Vinblastine—hematologic cancer	0.00111	0.00118	CcSEcCtD
Methacholine—Nausea—Nilotinib—hematologic cancer	0.00111	0.00118	CcSEcCtD
Methacholine—Nausea—Imatinib—hematologic cancer	0.0011	0.00117	CcSEcCtD
Methacholine—Headache—Vinblastine—hematologic cancer	0.00109	0.00116	CcSEcCtD
Methacholine—Hypotension—Gemcitabine—hematologic cancer	0.00109	0.00116	CcSEcCtD
Methacholine—Nausea—Cladribine—hematologic cancer	0.00108	0.00115	CcSEcCtD
Methacholine—Cardiac arrest—Epirubicin—hematologic cancer	0.00108	0.00115	CcSEcCtD
Methacholine—Syncope—Prednisolone—hematologic cancer	0.00108	0.00115	CcSEcCtD
Methacholine—Loss of consciousness—Etoposide—hematologic cancer	0.00107	0.00114	CcSEcCtD
Methacholine—Dizziness—Lenalidomide—hematologic cancer	0.00107	0.00113	CcSEcCtD
Methacholine—Cough—Etoposide—hematologic cancer	0.00106	0.00113	CcSEcCtD
Methacholine—Loss of consciousness—Prednisolone—hematologic cancer	0.00106	0.00112	CcSEcCtD
Methacholine—Vomiting—Melphalan—hematologic cancer	0.00105	0.00112	CcSEcCtD
Methacholine—Dizziness—Hydroxyurea—hematologic cancer	0.00105	0.00112	CcSEcCtD
Methacholine—Pruritus—Bortezomib—hematologic cancer	0.00105	0.00112	CcSEcCtD
Methacholine—Pruritus—Bleomycin—hematologic cancer	0.00104	0.00111	CcSEcCtD
Methacholine—Chest pain—Etoposide—hematologic cancer	0.00104	0.0011	CcSEcCtD
Methacholine—Nausea—Vinblastine—hematologic cancer	0.00104	0.0011	CcSEcCtD
Methacholine—Vomiting—Lenalidomide—hematologic cancer	0.00103	0.00109	CcSEcCtD
Methacholine—Pruritus—Vinorelbine—hematologic cancer	0.00103	0.00109	CcSEcCtD
Methacholine—Bradycardia—Prednisone—hematologic cancer	0.00102	0.00109	CcSEcCtD
Methacholine—Hypotension—Cisplatin—hematologic cancer	0.00101	0.00108	CcSEcCtD
Methacholine—Vomiting—Hydroxyurea—hematologic cancer	0.00101	0.00108	CcSEcCtD
Methacholine—Headache—Lenalidomide—hematologic cancer	0.00101	0.00107	CcSEcCtD
Methacholine—Cardiac arrest—Doxorubicin—hematologic cancer	0.000998	0.00106	CcSEcCtD
Methacholine—Headache—Hydroxyurea—hematologic cancer	0.000996	0.00106	CcSEcCtD
Methacholine—Syncope—Triamcinolone—hematologic cancer	0.000991	0.00105	CcSEcCtD
Methacholine—Nausea—Melphalan—hematologic cancer	0.000985	0.00105	CcSEcCtD
Methacholine—Dizziness—Bortezomib—hematologic cancer	0.000981	0.00104	CcSEcCtD
Methacholine—Pruritus—Thiotepa—hematologic cancer	0.000979	0.00104	CcSEcCtD
Methacholine—Loss of consciousness—Triamcinolone—hematologic cancer	0.000971	0.00103	CcSEcCtD
Methacholine—Shock—Prednisolone—hematologic cancer	0.000965	0.00103	CcSEcCtD
Methacholine—Cough—Triamcinolone—hematologic cancer	0.000964	0.00103	CcSEcCtD
Methacholine—Dizziness—Vinorelbine—hematologic cancer	0.000958	0.00102	CcSEcCtD
Methacholine—Nausea—Lenalidomide—hematologic cancer	0.000958	0.00102	CcSEcCtD
Methacholine—Pruritus—Thalidomide—hematologic cancer	0.000947	0.00101	CcSEcCtD
Methacholine—Nausea—Hydroxyurea—hematologic cancer	0.000945	0.001	CcSEcCtD
Methacholine—Vomiting—Bortezomib—hematologic cancer	0.000944	0.001	CcSEcCtD
Methacholine—Vomiting—Bleomycin—hematologic cancer	0.000936	0.000996	CcSEcCtD
Methacholine—Headache—Bortezomib—hematologic cancer	0.00093	0.000989	CcSEcCtD
Methacholine—Hypotension—Etoposide—hematologic cancer	0.000929	0.000988	CcSEcCtD
Methacholine—Vomiting—Vinorelbine—hematologic cancer	0.000921	0.00098	CcSEcCtD
Methacholine—Dizziness—Thiotepa—hematologic cancer	0.000915	0.000973	CcSEcCtD
Methacholine—Headache—Vinorelbine—hematologic cancer	0.000908	0.000965	CcSEcCtD
Methacholine—Pruritus—Alitretinoin—hematologic cancer	0.000901	0.000958	CcSEcCtD
Methacholine—Syncope—Betamethasone—hematologic cancer	0.000899	0.000956	CcSEcCtD
Methacholine—Syncope—Dexamethasone—hematologic cancer	0.000899	0.000956	CcSEcCtD
Methacholine—Pruritus—Ifosfamide—hematologic cancer	0.000891	0.000947	CcSEcCtD
Methacholine—Shock—Triamcinolone—hematologic cancer	0.000887	0.000943	CcSEcCtD
Methacholine—Dizziness—Thalidomide—hematologic cancer	0.000885	0.000941	CcSEcCtD
Methacholine—Nausea—Bortezomib—hematologic cancer	0.000882	0.000938	CcSEcCtD
Methacholine—Loss of consciousness—Betamethasone—hematologic cancer	0.000881	0.000937	CcSEcCtD
Methacholine—Loss of consciousness—Dexamethasone—hematologic cancer	0.000881	0.000937	CcSEcCtD
Methacholine—Vomiting—Thiotepa—hematologic cancer	0.00088	0.000936	CcSEcCtD
Methacholine—Nausea—Bleomycin—hematologic cancer	0.000875	0.00093	CcSEcCtD
Methacholine—Headache—Thiotepa—hematologic cancer	0.000867	0.000922	CcSEcCtD
Methacholine—Nausea—Vinorelbine—hematologic cancer	0.000861	0.000915	CcSEcCtD
Methacholine—Vomiting—Thalidomide—hematologic cancer	0.000851	0.000905	CcSEcCtD
Methacholine—Dizziness—Carmustine—hematologic cancer	0.00085	0.000904	CcSEcCtD
Methacholine—Dizziness—Alitretinoin—hematologic cancer	0.000842	0.000896	CcSEcCtD
Methacholine—Headache—Thalidomide—hematologic cancer	0.000839	0.000892	CcSEcCtD
Methacholine—Dizziness—Ifosfamide—hematologic cancer	0.000832	0.000885	CcSEcCtD
Methacholine—Pruritus—Gemcitabine—hematologic cancer	0.000824	0.000876	CcSEcCtD
Methacholine—Nausea—Thiotepa—hematologic cancer	0.000822	0.000874	CcSEcCtD
Methacholine—Vomiting—Carmustine—hematologic cancer	0.000817	0.000869	CcSEcCtD
Methacholine—Dizziness—Vincristine—hematologic cancer	0.000812	0.000863	CcSEcCtD
Methacholine—Vomiting—Alitretinoin—hematologic cancer	0.00081	0.000861	CcSEcCtD
Methacholine—Headache—Carmustine—hematologic cancer	0.000805	0.000856	CcSEcCtD
Methacholine—Shock—Betamethasone—hematologic cancer	0.000805	0.000856	CcSEcCtD
Methacholine—Shock—Dexamethasone—hematologic cancer	0.000805	0.000856	CcSEcCtD
Methacholine—Vomiting—Ifosfamide—hematologic cancer	0.0008	0.000851	CcSEcCtD
Methacholine—Bradycardia—Epirubicin—hematologic cancer	0.000798	0.000849	CcSEcCtD
Methacholine—Headache—Alitretinoin—hematologic cancer	0.000798	0.000848	CcSEcCtD
Methacholine—Nausea—Thalidomide—hematologic cancer	0.000795	0.000846	CcSEcCtD
Methacholine—Dizziness—Irinotecan—hematologic cancer	0.00079	0.00084	CcSEcCtD
Methacholine—Syncope—Prednisone—hematologic cancer	0.000783	0.000833	CcSEcCtD
Methacholine—Vomiting—Vincristine—hematologic cancer	0.00078	0.00083	CcSEcCtD
Methacholine—Headache—Vincristine—hematologic cancer	0.000769	0.000818	CcSEcCtD
Methacholine—Loss of consciousness—Prednisone—hematologic cancer	0.000767	0.000816	CcSEcCtD
Methacholine—Hypotension—Betamethasone—hematologic cancer	0.000764	0.000813	CcSEcCtD
Methacholine—Hypotension—Dexamethasone—hematologic cancer	0.000764	0.000813	CcSEcCtD
Methacholine—Nausea—Carmustine—hematologic cancer	0.000764	0.000812	CcSEcCtD
Methacholine—Vomiting—Mitoxantrone—hematologic cancer	0.00076	0.000808	CcSEcCtD
Methacholine—Vomiting—Irinotecan—hematologic cancer	0.00076	0.000808	CcSEcCtD
Methacholine—Nausea—Alitretinoin—hematologic cancer	0.000756	0.000804	CcSEcCtD
Methacholine—Headache—Mitoxantrone—hematologic cancer	0.000749	0.000796	CcSEcCtD
Methacholine—Headache—Irinotecan—hematologic cancer	0.000749	0.000796	CcSEcCtD
Methacholine—Nausea—Ifosfamide—hematologic cancer	0.000748	0.000795	CcSEcCtD
Methacholine—Vomiting—Gemcitabine—hematologic cancer	0.00074	0.000787	CcSEcCtD
Methacholine—Bradycardia—Doxorubicin—hematologic cancer	0.000739	0.000786	CcSEcCtD
Methacholine—Headache—Gemcitabine—hematologic cancer	0.000729	0.000776	CcSEcCtD
Methacholine—Nausea—Vincristine—hematologic cancer	0.000729	0.000775	CcSEcCtD
Methacholine—Nausea—Irinotecan—hematologic cancer	0.00071	0.000755	CcSEcCtD
Methacholine—Nausea—Mitoxantrone—hematologic cancer	0.00071	0.000755	CcSEcCtD
Methacholine—Pruritus—Etoposide—hematologic cancer	0.000703	0.000748	CcSEcCtD
Methacholine—Shock—Prednisone—hematologic cancer	0.000701	0.000745	CcSEcCtD
Methacholine—Nausea—Gemcitabine—hematologic cancer	0.000692	0.000735	CcSEcCtD
Methacholine—Vomiting—Cisplatin—hematologic cancer	0.00069	0.000734	CcSEcCtD
Methacholine—Dizziness—Etoposide—hematologic cancer	0.000657	0.000699	CcSEcCtD
Methacholine—Dizziness—Prednisolone—hematologic cancer	0.000648	0.00069	CcSEcCtD
Methacholine—Nausea—Cisplatin—hematologic cancer	0.000645	0.000685	CcSEcCtD
Methacholine—Pruritus—Triamcinolone—hematologic cancer	0.000638	0.000678	CcSEcCtD
Methacholine—Cough—Methotrexate—hematologic cancer	0.000637	0.000677	CcSEcCtD
Methacholine—Vomiting—Etoposide—hematologic cancer	0.000632	0.000672	CcSEcCtD
Methacholine—Headache—Etoposide—hematologic cancer	0.000623	0.000662	CcSEcCtD
Methacholine—Chest pain—Methotrexate—hematologic cancer	0.000621	0.000661	CcSEcCtD
Methacholine—Headache—Prednisolone—hematologic cancer	0.000614	0.000653	CcSEcCtD
Methacholine—Syncope—Epirubicin—hematologic cancer	0.000612	0.000651	CcSEcCtD
Methacholine—Loss of consciousness—Epirubicin—hematologic cancer	0.0006	0.000638	CcSEcCtD
Methacholine—Dizziness—Triamcinolone—hematologic cancer	0.000596	0.000634	CcSEcCtD
Methacholine—Cough—Epirubicin—hematologic cancer	0.000596	0.000634	CcSEcCtD
Methacholine—Nausea—Etoposide—hematologic cancer	0.00059	0.000628	CcSEcCtD
Methacholine—Nausea—Prednisolone—hematologic cancer	0.000582	0.000619	CcSEcCtD
Methacholine—Chest pain—Epirubicin—hematologic cancer	0.000581	0.000618	CcSEcCtD
Methacholine—Pruritus—Dexamethasone—hematologic cancer	0.000579	0.000616	CcSEcCtD
Methacholine—Pruritus—Betamethasone—hematologic cancer	0.000579	0.000616	CcSEcCtD
Methacholine—Vomiting—Triamcinolone—hematologic cancer	0.000573	0.00061	CcSEcCtD
Methacholine—Syncope—Doxorubicin—hematologic cancer	0.000567	0.000603	CcSEcCtD
Methacholine—Headache—Triamcinolone—hematologic cancer	0.000565	0.000601	CcSEcCtD
Methacholine—Hypotension—Methotrexate—hematologic cancer	0.000556	0.000592	CcSEcCtD
Methacholine—Loss of consciousness—Doxorubicin—hematologic cancer	0.000555	0.000591	CcSEcCtD
Methacholine—Cough—Doxorubicin—hematologic cancer	0.000551	0.000586	CcSEcCtD
Methacholine—Shock—Epirubicin—hematologic cancer	0.000548	0.000583	CcSEcCtD
Methacholine—Dizziness—Dexamethasone—hematologic cancer	0.000541	0.000575	CcSEcCtD
Methacholine—Dizziness—Betamethasone—hematologic cancer	0.000541	0.000575	CcSEcCtD
Methacholine—Chest pain—Doxorubicin—hematologic cancer	0.000538	0.000572	CcSEcCtD
Methacholine—Nausea—Triamcinolone—hematologic cancer	0.000536	0.00057	CcSEcCtD
Methacholine—Hypotension—Epirubicin—hematologic cancer	0.000521	0.000554	CcSEcCtD
Methacholine—Vomiting—Betamethasone—hematologic cancer	0.00052	0.000553	CcSEcCtD
Methacholine—Vomiting—Dexamethasone—hematologic cancer	0.00052	0.000553	CcSEcCtD
Methacholine—Headache—Betamethasone—hematologic cancer	0.000513	0.000545	CcSEcCtD
Methacholine—Headache—Dexamethasone—hematologic cancer	0.000513	0.000545	CcSEcCtD
Methacholine—Shock—Doxorubicin—hematologic cancer	0.000507	0.000539	CcSEcCtD
Methacholine—Pruritus—Prednisone—hematologic cancer	0.000504	0.000536	CcSEcCtD
Methacholine—Nausea—Betamethasone—hematologic cancer	0.000486	0.000517	CcSEcCtD
Methacholine—Nausea—Dexamethasone—hematologic cancer	0.000486	0.000517	CcSEcCtD
Methacholine—Hypotension—Doxorubicin—hematologic cancer	0.000482	0.000512	CcSEcCtD
Methacholine—Dizziness—Prednisone—hematologic cancer	0.000471	0.000501	CcSEcCtD
Methacholine—Vomiting—Prednisone—hematologic cancer	0.000453	0.000482	CcSEcCtD
Methacholine—Headache—Prednisone—hematologic cancer	0.000446	0.000475	CcSEcCtD
Methacholine—Nausea—Prednisone—hematologic cancer	0.000423	0.00045	CcSEcCtD
Methacholine—Pruritus—Methotrexate—hematologic cancer	0.000421	0.000448	CcSEcCtD
Methacholine—Pruritus—Epirubicin—hematologic cancer	0.000394	0.000419	CcSEcCtD
Methacholine—Dizziness—Methotrexate—hematologic cancer	0.000394	0.000419	CcSEcCtD
Methacholine—Vomiting—Methotrexate—hematologic cancer	0.000379	0.000403	CcSEcCtD
Methacholine—Headache—Methotrexate—hematologic cancer	0.000373	0.000397	CcSEcCtD
Methacholine—Dizziness—Epirubicin—hematologic cancer	0.000368	0.000392	CcSEcCtD
Methacholine—Pruritus—Doxorubicin—hematologic cancer	0.000365	0.000388	CcSEcCtD
Methacholine—Vomiting—Epirubicin—hematologic cancer	0.000354	0.000377	CcSEcCtD
Methacholine—Nausea—Methotrexate—hematologic cancer	0.000354	0.000376	CcSEcCtD
Methacholine—Headache—Epirubicin—hematologic cancer	0.000349	0.000371	CcSEcCtD
Methacholine—Dizziness—Doxorubicin—hematologic cancer	0.000341	0.000363	CcSEcCtD
Methacholine—Nausea—Epirubicin—hematologic cancer	0.000331	0.000352	CcSEcCtD
Methacholine—Vomiting—Doxorubicin—hematologic cancer	0.000328	0.000349	CcSEcCtD
Methacholine—Headache—Doxorubicin—hematologic cancer	0.000323	0.000344	CcSEcCtD
Methacholine—Nausea—Doxorubicin—hematologic cancer	0.000306	0.000326	CcSEcCtD
Methacholine—CHRM2—Signaling by GPCR—JAK1—hematologic cancer	3.3e-05	0.000586	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GZMB—hematologic cancer	3.3e-05	0.000586	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SMARCA4—hematologic cancer	3.29e-05	0.000584	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SH2B3—hematologic cancer	3.29e-05	0.000584	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GZMB—hematologic cancer	3.27e-05	0.00058	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CTNNA1—hematologic cancer	3.22e-05	0.000572	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NQO1—hematologic cancer	3.22e-05	0.000572	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CD44—hematologic cancer	3.22e-05	0.000572	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HSPB1—hematologic cancer	3.2e-05	0.000569	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCL3—hematologic cancer	3.2e-05	0.000569	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EIF4EBP1—hematologic cancer	3.2e-05	0.000569	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CTNNA1—hematologic cancer	3.19e-05	0.000566	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EIF4EBP1—hematologic cancer	3.17e-05	0.000563	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HSPB1—hematologic cancer	3.17e-05	0.000563	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCL3—hematologic cancer	3.17e-05	0.000563	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PTHLH—hematologic cancer	3.17e-05	0.000562	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SDC1—hematologic cancer	3.17e-05	0.000562	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PTHLH—hematologic cancer	3.13e-05	0.000557	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SDC1—hematologic cancer	3.13e-05	0.000557	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—IL2RA—hematologic cancer	3.11e-05	0.000553	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—IL2RA—hematologic cancer	3.08e-05	0.000548	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PTGER4—hematologic cancer	3.08e-05	0.000547	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—LCK—hematologic cancer	3.07e-05	0.000545	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PTGER4—hematologic cancer	3.05e-05	0.000542	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYCS—hematologic cancer	3.05e-05	0.000541	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—LCK—hematologic cancer	3.04e-05	0.000539	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—HSP90AA1—hematologic cancer	3.03e-05	0.000538	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—H3F3A—hematologic cancer	3e-05	0.000534	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—H3F3A—hematologic cancer	2.98e-05	0.000529	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PRKCZ—hematologic cancer	2.92e-05	0.000519	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PRKCZ—hematologic cancer	2.89e-05	0.000514	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CG—hematologic cancer	2.86e-05	0.000507	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CG—hematologic cancer	2.83e-05	0.000502	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PARP1—hematologic cancer	2.82e-05	0.000501	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PARP1—hematologic cancer	2.79e-05	0.000496	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FBXW7—hematologic cancer	2.78e-05	0.000493	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FBXW7—hematologic cancer	2.75e-05	0.000488	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CXCR4—hematologic cancer	2.72e-05	0.000484	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HDAC2—hematologic cancer	2.72e-05	0.000484	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HDAC2—hematologic cancer	2.7e-05	0.000479	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CXCR4—hematologic cancer	2.7e-05	0.000479	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GSTP1—hematologic cancer	2.68e-05	0.000477	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CBL—hematologic cancer	2.65e-05	0.000471	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CBL—hematologic cancer	2.63e-05	0.000467	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IL3—hematologic cancer	2.62e-05	0.000466	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IL3—hematologic cancer	2.6e-05	0.000462	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CG—hematologic cancer	2.59e-05	0.000461	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PTPN1—hematologic cancer	2.58e-05	0.000458	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CG—hematologic cancer	2.57e-05	0.000456	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PTPN1—hematologic cancer	2.56e-05	0.000454	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PTPN11—hematologic cancer	2.55e-05	0.000453	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ABCB1—hematologic cancer	2.54e-05	0.000452	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—RASGRP1—hematologic cancer	2.54e-05	0.000451	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SYK—hematologic cancer	2.53e-05	0.00045	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HSP90AA1—hematologic cancer	2.53e-05	0.00045	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PTPN11—hematologic cancer	2.52e-05	0.000448	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—RASGRP1—hematologic cancer	2.51e-05	0.000447	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CD—hematologic cancer	2.51e-05	0.000446	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SYK—hematologic cancer	2.51e-05	0.000445	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HSP90AA1—hematologic cancer	2.51e-05	0.000445	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CD—hematologic cancer	2.49e-05	0.000442	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CREB1—hematologic cancer	2.47e-05	0.000439	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GSTM1—hematologic cancer	2.47e-05	0.000438	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NCOR1—hematologic cancer	2.47e-05	0.000438	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CREB1—hematologic cancer	2.44e-05	0.000434	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—STAT1—hematologic cancer	2.44e-05	0.000434	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—STAT1—hematologic cancer	2.42e-05	0.000429	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CCL2—hematologic cancer	2.41e-05	0.000429	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—IL6R—hematologic cancer	2.41e-05	0.000428	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CCL2—hematologic cancer	2.39e-05	0.000425	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—IL6R—hematologic cancer	2.38e-05	0.000424	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3R1—hematologic cancer	2.37e-05	0.000421	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3R1—hematologic cancer	2.35e-05	0.000417	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—JAK2—hematologic cancer	2.3e-05	0.000409	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—MAP2K1—hematologic cancer	2.29e-05	0.000408	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GRB2—hematologic cancer	2.28e-05	0.000406	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—JAK2—hematologic cancer	2.28e-05	0.000405	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CD—hematologic cancer	2.28e-05	0.000405	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PDGFA—hematologic cancer	2.28e-05	0.000405	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—MAP2K1—hematologic cancer	2.27e-05	0.000404	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GRB2—hematologic cancer	2.26e-05	0.000402	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CD—hematologic cancer	2.26e-05	0.000401	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PDGFA—hematologic cancer	2.26e-05	0.000401	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—KITLG—hematologic cancer	2.24e-05	0.000399	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—KITLG—hematologic cancer	2.22e-05	0.000395	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—STAT5A—hematologic cancer	2.19e-05	0.00039	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CB—hematologic cancer	2.19e-05	0.000389	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—MTHFR—hematologic cancer	2.18e-05	0.000387	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CDKN2B—hematologic cancer	2.17e-05	0.000386	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—STAT5A—hematologic cancer	2.17e-05	0.000386	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CB—hematologic cancer	2.17e-05	0.000385	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CDKN2B—hematologic cancer	2.15e-05	0.000383	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3R1—hematologic cancer	2.15e-05	0.000382	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3R1—hematologic cancer	2.13e-05	0.000379	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CD86—hematologic cancer	2.1e-05	0.000374	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—JAK2—hematologic cancer	2.09e-05	0.000372	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CD86—hematologic cancer	2.08e-05	0.00037	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HES1—hematologic cancer	2.07e-05	0.000369	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—JAK2—hematologic cancer	2.07e-05	0.000368	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NCOR1—hematologic cancer	2.06e-05	0.000367	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HES1—hematologic cancer	2.05e-05	0.000365	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NCOR1—hematologic cancer	2.04e-05	0.000363	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CSF2—hematologic cancer	2.04e-05	0.000362	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGF1—hematologic cancer	2.04e-05	0.000362	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGF1—hematologic cancer	2.02e-05	0.000359	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CSF2—hematologic cancer	2.02e-05	0.000359	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FOXO1—hematologic cancer	2.01e-05	0.000357	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—IL2—hematologic cancer	2.01e-05	0.000357	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PDGFRB—hematologic cancer	2.01e-05	0.000357	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FOXO1—hematologic cancer	1.99e-05	0.000354	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—IL2—hematologic cancer	1.99e-05	0.000354	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PDGFRB—hematologic cancer	1.99e-05	0.000353	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CB—hematologic cancer	1.99e-05	0.000353	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PDGFRA—hematologic cancer	1.98e-05	0.000351	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PRKCG—hematologic cancer	1.97e-05	0.00035	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—JAK1—hematologic cancer	1.97e-05	0.00035	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CB—hematologic cancer	1.97e-05	0.00035	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	1.96e-05	0.000348	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	1.95e-05	0.000346	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—JAK1—hematologic cancer	1.95e-05	0.000346	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IL2RA—hematologic cancer	1.84e-05	0.000327	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CG—hematologic cancer	1.83e-05	0.000325	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—IL2—hematologic cancer	1.82e-05	0.000324	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	1.82e-05	0.000324	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TERT—hematologic cancer	1.82e-05	0.000323	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—IL2—hematologic cancer	1.81e-05	0.000321	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TERT—hematologic cancer	1.8e-05	0.00032	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PDGFB—hematologic cancer	1.77e-05	0.000315	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	1.76e-05	0.000312	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TSC2—hematologic cancer	1.73e-05	0.000308	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TSC2—hematologic cancer	1.72e-05	0.000305	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CREBBP—hematologic cancer	1.7e-05	0.000302	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGFR3—hematologic cancer	1.67e-05	0.000296	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	1.65e-05	0.000294	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MAPK14—hematologic cancer	1.65e-05	0.000293	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	1.64e-05	0.000291	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ESR1—hematologic cancer	1.62e-05	0.000288	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CD—hematologic cancer	1.61e-05	0.000286	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ESR1—hematologic cancer	1.6e-05	0.000285	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FN1—hematologic cancer	1.6e-05	0.000284	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ALB—hematologic cancer	1.59e-05	0.000282	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FN1—hematologic cancer	1.58e-05	0.000282	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—BAD—hematologic cancer	1.58e-05	0.000281	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NFKBIA—hematologic cancer	1.58e-05	0.000281	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NOTCH1—hematologic cancer	1.57e-05	0.000278	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—BAD—hematologic cancer	1.57e-05	0.000278	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	1.57e-05	0.000278	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	1.55e-05	0.000276	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CD80—hematologic cancer	1.53e-05	0.000273	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CG—hematologic cancer	1.53e-05	0.000272	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—KIT—hematologic cancer	1.53e-05	0.000272	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—NRAS—hematologic cancer	1.53e-05	0.000272	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3R1—hematologic cancer	1.52e-05	0.00027	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CD80—hematologic cancer	1.52e-05	0.00027	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	1.52e-05	0.00027	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—KIT—hematologic cancer	1.52e-05	0.00027	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	1.52e-05	0.00027	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PTPN11—hematologic cancer	1.5e-05	0.000267	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	1.49e-05	0.000265	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—MAPK3—hematologic cancer	1.47e-05	0.000261	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CREB1—hematologic cancer	1.46e-05	0.000259	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	1.45e-05	0.000258	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CREB1—hematologic cancer	1.44e-05	0.000257	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—BRAF—hematologic cancer	1.44e-05	0.000256	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCL2—hematologic cancer	1.43e-05	0.000253	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—BRAF—hematologic cancer	1.43e-05	0.000253	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IL6R—hematologic cancer	1.42e-05	0.000253	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CREBBP—hematologic cancer	1.42e-05	0.000252	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCL2—hematologic cancer	1.41e-05	0.000251	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IL6R—hematologic cancer	1.41e-05	0.00025	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	1.41e-05	0.00025	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CB—hematologic cancer	1.4e-05	0.000249	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MAP2K1—hematologic cancer	1.36e-05	0.000241	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CD—hematologic cancer	1.35e-05	0.000239	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	1.34e-05	0.000238	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3CA—hematologic cancer	1.33e-05	0.000237	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	1.33e-05	0.000237	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.32e-05	0.000235	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—KRAS—hematologic cancer	1.32e-05	0.000234	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	1.31e-05	0.000232	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGF2—hematologic cancer	1.29e-05	0.000229	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGF2—hematologic cancer	1.28e-05	0.000227	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3R1—hematologic cancer	1.27e-05	0.000226	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	1.26e-05	0.000224	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—JAK2—hematologic cancer	1.24e-05	0.00022	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—JAK2—hematologic cancer	1.22e-05	0.000217	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PTEN—hematologic cancer	1.21e-05	0.000216	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3CA—hematologic cancer	1.21e-05	0.000215	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MDM2—hematologic cancer	1.21e-05	0.000214	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	1.2e-05	0.000213	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MDM2—hematologic cancer	1.19e-05	0.000212	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MTOR—hematologic cancer	1.17e-05	0.000209	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CB—hematologic cancer	1.17e-05	0.000209	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MTOR—hematologic cancer	1.16e-05	0.000207	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	1.16e-05	0.000207	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—EP300—hematologic cancer	1.16e-05	0.000206	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—HRAS—hematologic cancer	1.12e-05	0.000199	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	1.11e-05	0.000197	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CDKN1B—hematologic cancer	1.1e-05	0.000196	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	1.09e-05	0.000194	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—AKT1—hematologic cancer	1.09e-05	0.000194	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CASP3—hematologic cancer	1.08e-05	0.000192	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	1.08e-05	0.000192	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IL2—hematologic cancer	1.08e-05	0.000192	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—IL6—hematologic cancer	1.07e-05	0.000191	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CASP3—hematologic cancer	1.07e-05	0.00019	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IL2—hematologic cancer	1.07e-05	0.00019	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—IL6—hematologic cancer	1.06e-05	0.000189	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCND1—hematologic cancer	1.05e-05	0.000187	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—JUN—hematologic cancer	1.05e-05	0.000186	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCND1—hematologic cancer	1.04e-05	0.000185	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—JUN—hematologic cancer	1.04e-05	0.000184	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	1.02e-05	0.000181	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PTEN—hematologic cancer	1.01e-05	0.00018	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	1.01e-05	0.000179	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PTEN—hematologic cancer	1e-05	0.000178	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	9.92e-06	0.000176	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	9.89e-06	0.000176	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	9.82e-06	0.000175	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	9.8e-06	0.000174	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EP300—hematologic cancer	9.67e-06	0.000172	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EP300—hematologic cancer	9.58e-06	0.00017	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SRC—hematologic cancer	9.4e-06	0.000167	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SRC—hematologic cancer	9.31e-06	0.000165	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	9.16e-06	0.000163	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	9.07e-06	0.000161	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—STAT3—hematologic cancer	9.07e-06	0.000161	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NRAS—hematologic cancer	9.05e-06	0.000161	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	8.98e-06	0.00016	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	8.96e-06	0.000159	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	8.67e-06	0.000154	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	8.58e-06	0.000152	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3CA—hematologic cancer	8.56e-06	0.000152	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MYC—hematologic cancer	8.43e-06	0.00015	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	8.41e-06	0.000149	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MYC—hematologic cancer	8.35e-06	0.000148	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	8.33e-06	0.000148	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—KRAS—hematologic cancer	7.79e-06	0.000138	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	7.71e-06	0.000137	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	7.15e-06	0.000127	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	7.08e-06	0.000126	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—AKT1—hematologic cancer	6.99e-06	0.000124	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TP53—hematologic cancer	6.92e-06	0.000123	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TP53—hematologic cancer	6.85e-06	0.000122	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HRAS—hematologic cancer	6.62e-06	0.000118	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	6.55e-06	0.000116	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IL6—hematologic cancer	6.34e-06	0.000113	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IL6—hematologic cancer	6.27e-06	0.000111	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AKT1—hematologic cancer	5.84e-06	0.000104	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	5.79e-06	0.000103	CbGpPWpGaD
